Quote:
|
Today’s treatments are not good enough. Based on the results in other areas of medicine, we should be able to do better. Our Council workgroup told us that the path to finding new treatments is long, expensive, and essential. But even with current treatments, we can do much better if we learn how to tailor these treatments to the needs of each individual. Going forward, NIMH will be looking for clinical trials that are personalized (using predictive biomarkers) or preemptive (focused on early intervention) to maximize public health impact. http://www.nimh.nih.gov/about/director/index_4.shtml
|
Hello, LovebirdsFlying. I think you have a good point. There is a lot of controversy right now about the cause of depression and the efficacy of its treatment. The science and practice in the mental health arena has to get better.
I also think it is not very helpful when those who disagree jump on a soapbox to promote their views.